USPTO Examiner DOLETSKI BLAINE G - Art Unit 1692

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18714848A LIPID COMPOUND CONTAINING CARBAMATE BOND AND APPLICATIONS THEREOFMay 2024January 2025Allow710NoNo
18609781Methods of producing and recovering levulinic acidMarch 2024December 2024Allow920YesNo
18584742SYNTHESIS PROCESS FOR HIGH PURITY ISOSULFAN BLUE USING FLASH CHROMATOGRAPHY IN COMMERCIAL PLANT SCALEFebruary 2024August 2024Allow600YesNo
17912975Compounds Comprising Perfluorinated Group, Photoinitiator Group, and Amide Linking GroupSeptember 2022December 2024Allow2711NoNo
17930717One Pot Synthesis of Urea (Meth)AcrylatesSeptember 2022March 2025Allow3001NoNo
17746615ARYL TERPENE ESTERSMay 2022November 2024Abandon3031NoNo
17746624TERPENE ESTER SURFACTANTSMay 2022December 2024Abandon3131NoNo
17746626FATTY ACID TERPENE ALCOHOL ESTERSMay 2022November 2024Allow3031YesNo
17577222SYNTHESIS OF INTERMEDIATES FOR PRODUCING PROSTACYCLIN DERIVATIVESJanuary 2022January 2025Abandon3640NoNo
17596380PROCESS FOR THE PRODUCTION OF PEROXYESTERSDecember 2021September 2024Allow3300YesNo
17611811METHOD FOR PRODUCING LEVULINIC ACID IN MOLTEN SALT HYDRATE FROM CELLULOSE HYDROLYSISNovember 2021February 2025Abandon3910YesNo
17610761METHOD FOR PREPARING GLYCOLIC ACIDNovember 2021January 2025Abandon3801NoNo
17609441DIAMONDOID COMPOUNDSNovember 2021February 2025Allow3911YesNo
17609154METHOD FOR THE PURIFICATION OF ISOCYANATESNovember 2021January 2025Abandon3901NoNo
17604694PROCESS FOR THE PRODUCTION OF ANHYDROUS METHANESULFONIC ACID FROM METHANE AND SO3October 2021December 2024Allow3810YesNo
17603759METHODS FOR PRODUCING CRYSTALLINE L-GLUFOSINATE AMMONIUM MONOHYDRATEOctober 2021October 2024Allow3601NoNo
17603603SYNTHETIC METHODS OF PREPARING ESKETAMINEOctober 2021July 2024Allow3300NoNo
17603488NOVEL ENOL-ACETATES(II)October 2021December 2024Abandon3810NoNo
17602881PROCESS FOR SEPARATION OF SATURATED AND UNSATURATED CARBOXYLIC ACIDSOctober 2021December 2024Abandon3810NoNo
17601065METHOD FOR SYNTHESIS OF ORGANIC IODIDES, A PEROVSKITE-FORMING COMPOSITION COMPRISING AN ORGANIC IODIDE AND A PHOTOVOLTAIC CELL WITH A PEROVSKITE LAYER OBTAINED THEREFROMOctober 2021September 2024Allow3501YesNo
17442371RHEOLOGY ADDITIVES BASED ON HYDROXYLATED DI-OR TRI-AMIDES AND MIXTURES THEROFSeptember 2021September 2024Allow3601YesNo
17438518FLOW SYNTHESIS PROCESS FOR THE PRODUCTION OF OSELTAMIVIRSeptember 2021January 2025Allow4110YesNo
17472468PROCESS FOR PREPARING ETHYLENICALLY UNSATURATED COMPOUNDS CONTAINING URETHANE GROUPSSeptember 2021November 2024Abandon3810NoNo
17436983METHOD FOR PRODUCING FORMIC ACIDSeptember 2021October 2024Abandon3810NoNo
17335821METAL DI-AMINO ACID CHELATES OR METAL TRI-AMINO ACID CHELATESJune 2021January 2025Abandon4311NoNo
17279200LYOPHILISATE OF TREOSULFANMarch 2021August 2024Allow4111YesNo
17265054PROCESSES AND CATAYLST SYSTEMS FOR PRODUCING MONOETHANOLAMINE FROM GLYCOLALDEHYDEFebruary 2021August 2024Allow4220YesNo
16329132PROCESS FOR PREPARING SALICYLOYL-L-CARNITINE HYDROCHLORIDEFebruary 2019February 2020Allow1200NoNo
16269218ZWITTERIONIC SURFACTANT CONTAINING ETHOXYLATE UNITSFebruary 2019September 2019Allow800YesNo
16201087IMMOBILIZED METALLOPORPHYRIN CATALYST AND ITS UTILIZATION IN MALEIC ACID PREPARATIONNovember 2018September 2019Allow1001YesNo
16016693METHOD FOR PREPARING STABILIZER CONTAINING PHOSPHATE-ESTERJune 2018March 2019Allow800YesNo
16062195DOPED HYDRIDOSILANE COMPOSITIONS, AND METHOD FOR PRODUCING SAMEJune 2018March 2019Allow900YesNo
15781623NOVEL COMPOUND, PHOTOPOLYMERIZATION INITIATOR COMPRISING SAID COMPOUND, AND PHOTOSENSITIVE RESIN COMPOSITION CONTAINING SAID PHOTOPOLYMERIZATION INITIATORJune 2018August 2019Allow1510YesNo
15780718PROCESS TO PRODUCE A BIO-PRODUCTJune 2018October 2019Allow1711YesNo
15985596NOVEL COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL SKIN DISEASEMay 2018April 2019Allow1120YesNo
15967463Method for preparing carboxylic esters from aldehydesApril 2018March 2020Allow2221YesNo
15851797Synthesis of Azelaic AcidDecember 2017May 2019Allow1710YesNo
15829008SELECTIVE AEROBIC OXIDATION OF DIMETHYLBIPHENYLSDecember 2017December 2018Allow1310YesNo
15552739P-TOLUIC ACID PRODUCING METHODAugust 2017August 2018Allow1100NoNo
15512595LIQUID THIOETHER CARBOXYLIC ACID ESTERSMarch 2017December 2018Allow2111YesNo
15320807METHODS FOR PRODUCING CHEMICAL PRODUCTS WITH OPERATION INTERRUPTIONSDecember 2016October 2019Allow3450YesNo
15320512PRODUCTION INTERMEDIATE OF POLYMERIZABLE COMPOUND, PRODUCTION METHOD FOR SAME, COMPOSITION, AND STABILIZATION METHODDecember 2016March 2018Allow1530NoNo

Appeals Overview

No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.

Examiner DOLETSKI, BLAINE G - Prosecution Strategy Guide

Executive Summary

Examiner DOLETSKI, BLAINE G works in Art Unit 1692 and has examined 39 patent applications in our dataset. With an allowance rate of 71.8%, this examiner has a below-average tendency to allow applications. Applications typically reach final disposition in approximately 33 months.

Allowance Patterns

Examiner DOLETSKI, BLAINE G's allowance rate of 71.8% places them in the 27% percentile among all USPTO examiners. This examiner has a below-average tendency to allow applications.

Office Action Patterns

On average, applications examined by DOLETSKI, BLAINE G receive 1.10 office actions before reaching final disposition. This places the examiner in the 16% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by DOLETSKI, BLAINE G is 33 months. This places the examiner in the 26% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +54.3% benefit to allowance rate for applications examined by DOLETSKI, BLAINE G. This interview benefit is in the 96% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 25.0% of applications are subsequently allowed. This success rate is in the 28% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 16.7% of cases where such amendments are filed. This entry rate is in the 11% percentile among all examiners. Strategic Recommendation: This examiner rarely enters after-final amendments compared to other examiners. You should generally plan to file an RCE or appeal rather than relying on after-final amendment entry. Per MPEP § 714.12, primary examiners have discretion in entering after-final amendments, and this examiner exercises that discretion conservatively.

Petition Practice

When applicants file petitions regarding this examiner's actions, 50.0% are granted (fully or in part). This grant rate is in the 59% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 3% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 3% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prioritize examiner interviews: Interviews are highly effective with this examiner. Request an interview after the first office action to clarify issues and potentially expedite allowance.
  • Plan for RCE after final rejection: This examiner rarely enters after-final amendments. Budget for an RCE in your prosecution strategy if you receive a final rejection.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.